Switch to:
Synageva BioPharma Corp (NAS:GEVA)
EPS (Diluted)
\$-6.34 (TTM As of Mar. 2015)

Synageva BioPharma Corp's diluted earnings per share (Diluted EPS) for the three months ended in Mar. 2015 was \$-1.63. Its diluted earnings per share (Diluted EPS) for the trailing twelve months (TTM) ended in Mar. 2015 was \$-6.34.

Synageva BioPharma Corp's basic earnings per share (Basic EPS) for the three months ended in Mar. 2015 was \$-1.63. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2015 was \$-6.34.

Synageva BioPharma Corp's earnings per share without non-recurring items for the three months ended in Mar. 2015 was \$-1.63. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2015 was \$-6.34.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using earnings per share (NRI) data.

Definition

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Synageva BioPharma Corp's Diluted EPS for the fiscal year that ended in Dec. 2014 is calculated as

 Diluted EPS (A: Dec. 2014 ) = (Net Income - Preferred Dividends) / Total Shares Outstanding = (-192.648 - 0) / 32.719 = -5.89

Synageva BioPharma Corp's Diluted EPS for the quarter that ended in Mar. 2015 is calculated as

 Diluted EPS (Q: Mar. 2015 ) = (Net Income - Preferred Dividends) / Total Shares Outstanding = (-59.601 - 0) / 36.495 = -1.63

Synageva BioPharma Corp EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2015 was -1.52 (Jun. 2014 ) + -1.46 (Sep. 2014 ) + -1.733 (Dec. 2014 ) + -1.63 (Mar. 2015 ) = \$-6.34

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a companys cash flow is better indicator of the companys earnings power.

If a companys earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Related Terms

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 eps_diluted -1.85 1.70 6.20 1.80 2.75 -343.10 -8.58 -1.90 -3.40 -5.89

Synageva BioPharma Corp Quarterly Data

 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 eps_diluted -0.62 -0.54 -0.81 -1.02 -1.00 -1.16 -1.52 -1.46 -1.73 -1.63
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)